Gastroenterology Research and Practice / 2015 / Article / Tab 2 / Research Article
Nuclear Factor Kappa B, Matrix Metalloproteinase-1, p53, and Ki-67 Expressions in the Primary Tumors and the Lymph Node Metastases of Colorectal Cancer Cases Table 2 NF-κ B, MMP-1, p53, and Ki-67 expressions in the primary tumor and the metastatic lymph nodes.
Colon ( ) Rectum ( ) All tumors ( ) Primary tumor Metastatic lymph node Primary tumor Metastatic lymph node Primary tumor Metastatic lymph node NF-κ B Negative 11 (17.2%) 6 (9.4%) 7 (15.2%) 4 (8.7%) 18 (16.4%) 10 (9.1%) Weak 6 (9.4%) 5 (7.8%) 6 (13%) 6 (13%) 12 (10.9%) 11 (10%) Moderate 20 (31.2%) 22 (34.4%) 14 (30.5%) 13 (28.3%) 34 (30.9%) 35 (31.8%) Strong 27 (42.2%) 31 (48.4%) 19 (41.3%) 23 (50%) 46 (41.8%) 54 (49.1%) MMP-1 Negative 12 (18.8%) 21 (32.8%) 8 (17.4%) 15 (32.6%) 20 (18.2%) 36 (32.7%) Weak 29 (45.3%) 16 (25%) 21 (45.7%) 11 (23.9%) 50 (45.5%) 27 (24.6%) Moderate 14 (21.8%) 25 (39.1%) 11 (23.9%) 19 (41.3%) 25 (22.7%) 44 (40%) Strong 9 (14.1%) 2 (3.1%) 6 (13%) 1 (2.2%) 15 (13.6%) 3 (2.7%) p53 Negative 5 (7.8%) 2 (3.1%) 4 (8.7%) 1 (2.2%) 9 (8.2%) 3 (2.7%) Weak 11 (17.2%) 6 (9.4%) 13 (28.3%) 4 (8.7%) 24 (21.8%) 10 (9.1%) Moderate 31 (48.4%) 36 (56.3%) 19 (41.3%) 23 (50%) 50 (45.5%) 59 (53.6%) Strong 17 (26.6%) 20 (31.2%) 10 (21.7%) 18 (39.1%) 27 (24.5%) 38 (34.6%) Ki-67 Negative 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) Weak 32 (50%) 13 (20.3%) 20 (43.5%) 8 (17.4%) 52 (47.3%) 21 (19.1%) Moderate 21 (32.8%) 31 (48.4%) 15 (32.6%) 18 (39.1%) 36 (32.7%) 49 (44.5%) Strong 11 (17.2%) 20 (31.3%) 11 (23.9%) 20 (43.5%) 22 (20%) 40 (36.4%)